Abiraterone
Abiraterone, Abirtega, YONSA, Zytiga
Cytochrome P450 17A1 Inhibitor
NADAC/unit
$0.8324
No Shortage
Tier 1: 70.5%
PA Req: 286.3%
12 Manufacturers
19 ANDAs
Abiraterone acetate tablets are indicated in combination with prednisone for the treatment of patients with Metastatic castration-resistant prostate cancer (CRPC) Metastatic high-risk castration-se....
vs. brand Abiraterone: Generic saves up to 92% per unit
Generic Manufacturers
AMNEAL PHARMACEUTICALS OF NEW YORK LLCAPOTEX INCDR REDDYS LABORATORIES LTDFLORIDA PHARMACEUTICAL PRODUCTS LLCGLENMARK SPECIALTY SAHIKMA PHARMACEUTICALS LLCJANSSEN BIOTECH INCMSN LABORATORIES PRIVATE LTDMYLAN PHARMACEUTICALS INCNOVUGEN ONCOLOGY SDN BHDQILU PHARMACEUTICAL CO LTDRISING PHARMA HOLDINGS INCSUN PHARMACEUTICAL INDUSTRIES LTDWOCKHARDT BIO AG
Explore in the Ecosystem
Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.